No abstract available
MeSH terms
-
Anticholesteremic Agents / economics*
-
Anticholesteremic Agents / pharmacology
-
Clinical Trials, Phase III as Topic
-
Heart Disease Risk Factors
-
Humans
-
Lipoproteins, LDL / drug effects
-
RNA, Small Interfering / economics*
-
RNA, Small Interfering / pharmacology
Substances
-
ALN-PCS
-
Anticholesteremic Agents
-
Lipoproteins, LDL
-
RNA, Small Interfering